SEC Form 5 · accession 0001264931-15-000082
Immune Therapeutics, Inc. · IMUN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eugene Youkilis
Officer — PRESIDENT · Director
Period of report
Dec 31, 2014
Accepted (ET)
Feb 12, 2015 · 5:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001559356
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | Sep 30, 2014 | J | 88,683 | $0.25 | A | 1,088,683 | D | |
| COMMON STOCKF2 | Dec 23, 2014 | J | 33,125 | — | A | 1,121,808 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Inadvertently omitted filing Form 4 for September 30, 2014 transaction. The reporting person acquired these shares in full satisfaction of a $22,170.78 balance owed in connection with the reporting person's employment as president of the issuer.
- F2Inadvertently omitted filing Form 4 for December 23, 2014 transaction. The reporting person acquired these shares from the Nicholas P. Plotnikoff Family Trust pursuant to a Second Amended Plan of Liquidation approved by the U.S. Bankruptcy Court for the District of Delaware due to the reporting person's status as an unsecured creditor.